|
| 赛伦生物(688163)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-09-11 | 6384.80 | 59.00% | 10822.00 | 0.00 | 4437.20 | 41.00% | 追加承诺限售股份上市流通 | | 2024-03-11 | 121.10 | 1.12% | 4437.20 | 6384.80 | 4282.10 | 39.57% | 首发战略配售股份 | | 2023-09-11 | 34.00 | 0.31% | 4316.10 | 6505.90 | 4282.10 | 39.57% | 追加承诺限售股份上市流通 | | 2023-03-13 | 1697.20 | 15.68% | 4282.10 | 6539.90 | 2584.90 | 23.89% | 首发原股东限售股份 | | 2022-09-13 | 108.54 | 1.00% | 2584.90 | 8237.10 | 2584.90 | 23.89% | 首发机构配售股份 | | 2022-03-11 | 2476.36 | 22.88% | 2476.36 | 8345.64 | 2476.36 | 22.88% | 首发一般股份 |
|